Literature DB >> 15964244

A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system.

Mark J Osborn1, Angela Panoskaltsis-Mortari, Ron T McElmurry, Scott K Bell, Dario A A Vignali, Martin D Ryan, Andrew C Wilber, R Scott McIvor, Jakub Tolar, Bruce R Blazar.   

Abstract

The 2A-like sequences from members of the picornavirus family were utilized to construct a tricistronic vector bearing the human iduronidase (IDUA) gene along with the firefly luciferase and DsRed2 reporter genes. The 2A-like sequences mediate a cotranslational cleavage event resulting in the release of each individual protein product. Efficient cleavage was observed and all three proteins were functional in vitro and in vivo, allowing for supratherapeutic IDUA enzyme levels and the coexpression of luciferase and DsRed2 expression, which enabled us to track gene expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964244     DOI: 10.1016/j.ymthe.2005.04.013

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  29 in total

1.  Acquiring transgenic tobacco plants with insect resistance and glyphosate tolerance by fusion gene transformation.

Authors:  He Sun; Zhihong Lang; Li Zhu; Dafang Huang
Journal:  Plant Cell Rep       Date:  2012-07-10       Impact factor: 4.570

2.  An improved and robust DNA immunization method to develop antibodies against extracellular loops of multi-transmembrane proteins.

Authors:  Meredith Hazen; Sunil Bhakta; Rajesh Vij; Steven Randle; Dara Kallop; Vicki Chiang; Isidro Hötzel; Bijay S Jaiswal; Karen E Ervin; Bing Li; Robby M Weimer; Paul Polakis; Richard H Scheller; Jagath R Junutula; Jo-Anne S Hongo
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

3.  Reciprocal modulation between amyloid precursor protein and synaptic membrane cholesterol revealed by live cell imaging.

Authors:  Claire E DelBove; Claire E Strothman; Roman M Lazarenko; Hui Huang; Charles R Sanders; Qi Zhang
Journal:  Neurobiol Dis       Date:  2019-03-15       Impact factor: 5.996

4.  Sustained interactions between T cell receptors and antigens promote the differentiation of CD4⁺ memory T cells.

Authors:  Chulwoo Kim; Theodore Wilson; Kael F Fischer; Matthew A Williams
Journal:  Immunity       Date:  2013-09-19       Impact factor: 31.745

5.  Efficient Therapeutic Protein Expression Using Retroviral Replicating Vector with 2A Peptide in Cancer Models.

Authors:  Andrew Hofacre; Kader Yagiz; Daniel Mendoza; Fernando Lopez Espinoza; Anthony W Munday; Cynthia Burrascano; Oded Singer; Harry E Gruber; Douglas J Jolly; Amy H Lin
Journal:  Hum Gene Ther       Date:  2018-04-02       Impact factor: 5.695

6.  Synthetic zinc finger nuclease design and rapid assembly.

Authors:  Mark J Osborn; Anthony P DeFeo; Bruce R Blazar; Jakub Tolar
Journal:  Hum Gene Ther       Date:  2011-08-10       Impact factor: 5.695

7.  Dual transgene strategy for live visualization of chromatin and plasma membrane dynamics in murine embryonic stem cells and embryonic tissues.

Authors:  Sonja Nowotschin; Guy S Eakin; Anna-Katerina Hadjantonakis
Journal:  Genesis       Date:  2009-05       Impact factor: 2.487

8.  Co-expression of two fibrolytic enzyme genes in CHO cells and transgenic mice.

Authors:  Miaorong Huang; Zicong Li; Xiaoling Huang; Wenchao Gao; Cailin Zhu; Hui Xu; Yujuan Yuan; Liang Shuai; Ruiai Chen
Journal:  Transgenic Res       Date:  2013-01-22       Impact factor: 2.788

9.  Cooperation between molecular targets of costimulation in promoting T cell persistence and tumor regression.

Authors:  Baohua Zhao; Aihua Song; Rizwanul Haque; Fengyang Lei; Lauren Weiler; Xiaofang Xiong; Yuzhang Wu; Michael Croft; Jianxun Song
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

10.  Targeting of the CNS in MPS-IH using a nonviral transferrin-alpha-L-iduronidase fusion gene product.

Authors:  Mark J Osborn; Ron T McElmurry; Brandon Peacock; Jakub Tolar; Bruce R Blazar
Journal:  Mol Ther       Date:  2008-06-03       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.